CRO" running radically faster, more reliable clinical trials, has announced their collaboration with the Clinical Data Interchange Standards Consortium (CDISC), to accelerate the generation of ...

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial ...

BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced the completion of enrollment and dosing for the low-dose cohort ...

Koh Young Technology surges 64% as FDA approves surgical robots for U.S. market Koh Young Technologys stock skyrockets as it breaks into the U.S. with innovative surgical robots.

We support drug discovery and cell medicine development by providing iPS cells and other cell products that meet PMDA and FDA standards to pharmaceutical and cell medicine development companies so ...

It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response in patients, however, there has recently been an increased demand for type O female blood-derived iPSCs.

Riding the momentum of FDA approval, Koh Young aims to sell more ... from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) in the first half of this year, paving the way for significant ...

Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...